Welcome to Knowledge Base!

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Categories
All

Products-AspenTech Pharma Suite

Unlocking Operational Excellence with Aspen SeisEarth™ - A Comprehensive Solution for Seismic Interpretation and Visualization

A Comprehensive Seismic Interpretation Solution

Aspen SeisEarth™ is a cutting-edge integrated solution that revolutionizes seismic interpretation and visualization across multiple surveys. With a strong focus on structural and stratigraphic interpretation, this platform enables seamless collaboration among multiple users within a shared environment. This unified approach enhances decision-making processes and streamlines workflows, significantly boosting operational efficiency.

Efficiency and Interactivity in Interpretation

The efficiency and interactivity features of Aspen SeisEarth™ set it apart as a top-tier seismic interpretation tool. By providing consistency between different views and leveraging high-speed graphics and modern workstations, interpreters can accelerate the interpretation process. The software's advanced capabilities allow for enhanced productivity and easier data sharing, fostering a collaborative environment for informed decision-making.

Enhanced Productivity and Cost-Effectiveness

One of the key advantages of Aspen SeisEarth™ is its ability to predict rock property volumes from seismic attributes using a neural network. This innovative workflow not only reduces the turnaround time for inversion projects but also generates multiple rock property volumes simultaneously, without the need for specialized quantitative interpretation expertise. Such advancements not only enhance productivity but also contribute significantly to cost-effectiveness in exploration and production endeavors.

Efficient Data Management and Connectivity

Aspen SeisEarth™ excels in efficient data management and interoperability. By connecting to the OSDU® Data Platform and third-party databases, the software enables quick project startups with minimal preparation. This seamless connectivity streamlines workflows and ensures that interpreters can focus their efforts on analysis and decision-making, rather than data handling and manipulation, ultimately saving valuable time and resources.

Innovative Technologies for Enhanced Decision-Making

The incorporation of Artificial Intelligence (AI) and machine learning in Aspen SeisEarth™ further enhances the decision-making process in subsurface exploration and production. By leveraging AI-driven insights, interpreters can gain deeper understandings of geological data relationships and optimize their workflows for improved outcomes. The platform's innovative features empower interpreters to make informed, data-driven decisions that drive operational excellence and success.

Empowering the Pharmaceutical Industry: GSK's Future-Ready Supply Chain with AspenTech Pharma Suite

Introduction to AspenTech Pharma Suite

GlaxoSmithKline (GSK) has successfully implemented Aspen Mtell® from AspenTech to bolster the resilience and reliability of their pharmaceutical supply chains. By leveraging predictive and prescriptive maintenance solutions offered by AspenTech, GSK has managed to proactively address potential issues, thus avoiding unplanned production downtime.

Read article

Seizing New Opportunities: AspenTech Pharma Suite's Roadmap for Smarter Manufacturing

Pharma Industry's Digital Transformation

The AspenTech Pharma Suite's report on the future of digital transformation and manufacturing in the pharmaceutical industry is based on a survey of 400 professionals in the US and Europe. The study also includes insights from industry leaders at GSK, Roche, Merck KGaA Darmstadt, Germany, and Kashiv BioSciences. Among the key topics covered in the report are the changing confidence levels of pharma manufacturers in digital transformation, the hurdles faced in leveraging technology for revenue growth while enhancing access to medicine, and the initiatives prioritized for smarter manufacturing.

Read article

Empowering Power Reliability with AspenTech Microgrid Management System

Optimizing Power Reliability and Efficiency

AspenTech Microgrid Management System™ (MMS) offers a comprehensive solution to deliver renewable power and manage on-site storage and cogeneration, ensuring optimized reliability, availability, and security of power for energy-critical assets and infrastructure. This system enables users to achieve uninterrupted power supply and operational continuity through balanced generation, demand, and storage. By leveraging a combination of renewables, power storage, virtual renewables (VPP), and grid power, businesses can align their operating OPEX and carbon neutrality objectives, minimize OPEX, and reduce their carbon footprint simultaneously.

Read article

Revolutionizing the Pharmaceutical Industry with AspenTech Pharma Suite

The Power of AspenTech Pharma Suite

AspenTech Pharma Suite is a cutting-edge solution designed to revolutionize and optimize pharmaceutical operations. This comprehensive suite of tools offers pharmaceutical companies a range of capabilities, from process optimization to supply chain management and regulatory compliance. The power of AspenTech Pharma Suite lies in its ability to streamline processes, improve efficiency, and ensure regulatory compliance at every step of the pharmaceutical production cycle.

Read article

Revolutionizing Pharma Manufacturing: AspenTech Pharma Suite's Roadmap to Smarter Operations

Challenges in Pharma Manufacturing Landscape

The pharmaceutical industry faces unprecedented challenges in today's complex landscape. From geopolitical tensions to disruptions in the supply chain caused by the pandemic, companies are under immense pressure to navigate these obstacles while meeting the growing demand for faster time-to-market solutions. A recent study by FT Longitude, involving insights from 400 experts in drug development and manufacturing, as well as professionals from renowned companies like GSK, Roche, Merck KGaA (Darmstadt Germany), and Kashiv BioSciences, sheds light on the future direction of drug manufacturing in the next 3-5 years.

Read article